Login
Subscribe
Take a FREE Trial
About Us
Contact us
RSS
20 May 2013
Search
The Pharma Letter
Home
7 Day Premium Trial
Pharmaceuticals
Biotechnology
Generics
Events
Companies
Drugs
Subscribe
Companies
Top Ten Companies //
Browse A - Z of companies
Merck KGaA
(Merck)
Merck
(Merck KGaA)
Pfizer
Roche
Novartis
GlaxoSmithKline
(GSK)
GSK
(GlaxoSmithKline)
Bristol-Myers Squibb
Lilly
Bayer
Browse the A - Z of Companies
#
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
K
K-V Pharmaceutical
KAI Pharmaceuticals
Kaken Pharma
Kaketsuken
Kalbe Pharma
KaloBios Pharmaceuticals
KalVista Pharmaceuticals
Kamada
Kanghong Sagent (Chengdu) Pharmaceutical
Karalex Pharma
Karo Bio
Karolinska Development
KDR Biotech
Kemira
Kemwell
Kent Pharmaceutical
Keryx Biopharmaceuticals
Kevelt
Kiadis Pharma
Kilitch Drugs
Kinex Pharmaceuticals
King Pharmaceuticals
Kitov Pharmaceuticals
Knome
Knopp Neurosciences
Kony Pharma
Korea Kolmar
Kos Pharmaceuticals
Kowa Pharmaceuticals
Kunwha Pharma
Kusum Pharma
KV Pharmaceutical
Kwang Dong Pharmaceutical
Kymab
Kyorin Pharmaceuticals
Kyowa Hakko
Kyowa Hakko Kirin
Kyowa Pharmaceuticals
KYTHERA
KYTHERA Biopharmaceuticals
Hot Topics
Most Read
Elan makes "transformational" acquisitions and a divestment
Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
SciClone gains China rights to Zensun's Neucardin
Bristol-Myers' data on Yervoy and nivolumab causes a stir
Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
Elan makes "transformational" acquisitions and a divestment
Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
SciClone gains China rights to Zensun's Neucardin
Bristol-Myers' data on Yervoy and nivolumab causes a stir
Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member